Our goal
At Tailor Bio, we aim to make precision medicine a reality for the deadliest cancers by providing new insight into chromosomal instability (CIN).
CIN is a genomic phenomenon present in 80% of all cancers and extreme CIN is typically found in more aggressive, difficult to treat cancers. We are focused on tackling this issue by developing a pan-cancer precision medicine platform.
Our platform utilises our unique understanding of CIN to help identify new therapeutic targets and improve patient stratification for more targeted and effective treatments.
